Literature DB >> 17268837

Rectal GIST presenting as a submucosal calculus.

Mark Testroote1, Marije Hoornweg, Steven Rhemrev.   

Abstract

This case report presents an incidental finding of a rectal GIST (gastrointestinal stromal tumor) presenting as a submucosal calculus, not previously reported. A 53-year-old man without a significant medical history presented with abdominal pain in the left lower quadrant, and with constipation. Upon rectal examination, a hard submucosal swelling was palpated 4 cm from the anus, at 3 o'clock, in the left rectum wall. X-ray photos, computerized tomography (CT)-scan and a magnetic resonance imaging (MRI) scan clearly showed a calculus. Excision revealed a turnip-like lesion, 3.1 x 2.3 x 1.8 cm. Analysis showed it was a rectal GIST, a rare mesenchymal tumor of the gastrointestinal tract, which expressed CD117 (or c-kit, a marker of kit-receptor tyrosine kinase) and CD34. Calcification is not a usual clinicopathological feature of GISTs [1-3], and although a number of rectal GISTs have been reported [4-9], we have found no cases so far of rectal GIST presenting as a submucosal calculus. In general, GISTs are rare mesenchymal tumors of the gastrointestinal tract (nerve tissue, smooth muscle). Histology and immunohistochemistry discriminate gastrointestinal stromal tumors from leiomyomas and neurinomas. The most important location is the stomach; the rectal location is rare. Usually, the classic signs of malignancy such as cellular invasion and metastasis are missing. A set of histologic criteria stratifies GIST for risk of malignant behavior such as mitotic activity and tumor size, cellular pleomorphism, developmental stage of the cell and quantity of cytoplasma [7,13]. Tumors with a high mitotic activity and size above 5 cm are considered malignant. Recent pharmacological advances such as tyrosine kinase inhibitors have determined c-kit (i.e., CD117) as the most important marker, amongst others. C-kit positive tumors respond extremely well to chemotherapy with Imatinib (Glivec, Gleevec) [10-12].

Entities:  

Mesh:

Year:  2007        PMID: 17268837      PMCID: PMC1914226          DOI: 10.1007/s10620-006-9160-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


Case Report

A 53-year-old man without significant medical history presented with abdominal pain in the left lower quadrant and constipation. He got up that morning with a cramping abdominal ache that lasted over the day. He was nauseous, had vomited once, and ructus was present. There had been a small amount of hard stool and discomfort during defecation initially, but after the general practitioner had administered laxatives, he had liquid diarrhea. There was no complaint of constipation on a regular basis; this was a new finding. Tenesmus was absent. There was no bleeding or mucous discharge. He was feverish, with a temperature of 38.2°C. On examination, the abdomen was slightly distended. Auscultation showed diminished intestinal peristalsis, without borborygmi, and percussion was tympanic. Upon palpation, the abdomen was supple: there was no reflex rigidity nor guarding, and no rebound tenderness. Upon rectal examination, a hard submucosal swelling was palpated 4 cm from the anus, at 3 o’clock, in the left rectum wall. At the time, this was considered an accidental finding that was to be investigated later. There were no specific deviations in the lab results. Ultrasound investigation displayed some hydronephrosis of the left kidney and a stone (size: 0.13×0.7 cm) of the left ureter. X-ray photos displayed a spherical lesion, projecting in the pelvis and situated in the rectum, and some phleboliths projecting on the left colon, but not the ureter stone (Fig. 1). Proctoscopy was not conclusive, so further investigation was performed. A computerized tomography (CT) scan and a magnetic resonance imaging (MRI) scan also clearly showed the submucosal calculus (Figs. 2 and 3).
Fig. 1

X-ray photo showing the rectal calculus projecting in the pelvis (thick arrow) above the pubic symphysis and the phleboliths projecting on the left colon (thin arrow)

Fig. 2

Computerized tomography (CT) scan showing the rectal calculus in the center (arrow)

Fig. 3

Magnetic resonance imaging (MRI) scan. The arrow shows the rectal calculus in the rectum wall

X-ray photo showing the rectal calculus projecting in the pelvis (thick arrow) above the pubic symphysis and the phleboliths projecting on the left colon (thin arrow) Computerized tomography (CT) scan showing the rectal calculus in the center (arrow) Magnetic resonance imaging (MRI) scan. The arrow shows the rectal calculus in the rectum wall Excision of the rectal calculus in the operating room Excision revealed a turnip-like lesion, dimensions 3.1× 2.3×1.8 cm Our patient was diagnosed with abdominal pain and constipation based on a ureter stone and slight hydronephrosis of the left kidney, with coincidental finding of a rectal tumor. He was sent home with adequate analgesia and spontaneously released the ureter stone. An appointment was made for elective excision of the rectal calculus. Transanal excision was performed in the operating room (Fig. 4) and revealed a turnip-like lesion, dimensions 3.1×2.3×1.8 cm (Fig. 5). No normal tissue margins were excised because the tumor was not connected to the surrounding tissues. After surgery, the patient went home and recovered well, without any further complaints or complications.
Fig. 4

Excision of the rectal calculus in the operating room

Fig. 5

Excision revealed a turnip-like lesion, dimensions 3.1× 2.3×1.8 cm

The calculus was analyzed and consisted of fibroid and bony tissue, together with bundles of spindle-shaped cells with cigar-like nuclei. A partially calcified leiomyoma was considered at first, but supplementary immunoperoxidase analysis showed that the spindle-shaped cells were positive for CD117 (c-kit) and CD34. Unfortunately, histopathologic slides showing CD117 staining are not available to us. There was some focally positive smooth muscle actin, and MIB1 expression appeared negative. The mitotic count was low: fewer than five mitoses per 50 HPF. Only then did this analysis lead to the conclusion of rectal GIST, with extended calcification and ossification. It was classified as low-risk GIST because of the size (between 2 and 5 cm) and low mitotic count (Table 1).
Table I

Prognosis of primary GIST

RiskSize (cm)Mitotic count (per 50 HPF)
Very low risk<2<5
Low risk2–5<5
Intermediate risk<56–10
5–10<5
High risk>5>5
>10>Any mitotic rate
Any tumor>10

Note. from Fletcher et al (13). Abbreviations: HPF, high-power field.

Prognosis of primary GIST Note. from Fletcher et al (13). Abbreviations: HPF, high-power field.

Conclusion

Calcification is not a usual clinicopathologic feature of GISTs [1-3], and although a number of rectal GISTs have been reported, we have found no cases so far of rectal GIST presenting as a submucosal calculus. Furthermore, in the literature we found no cases of calcified GIST in other sites of the body. Expression of CD117 (c-kit) and CD34 proved that our calculus was in fact a rectal GIST. Calcification might be explained by internal bleeding of the tumor. The abdominal pain of our patient could be explained entirely by the ureteral stone. The rectal tumor might only explain the constipation. Because of the unpredictable biological behavior of gastrointestinal stromal tumors, the prognosis for our patient is uncertain, in spite of the low-risk character. For this reason, at multidisciplinary oncological deliberation, an expectant policy with regular follow-up was arranged.
  13 in total

Review 1.  Gastrointestinal stromal tumors (GIST): C-kit mutations, CD117 expression, differential diagnosis and targeted cancer therapy with Imatinib.

Authors:  Chandu M V de Silva; Robin Reid
Journal:  Pathol Oncol Res       Date:  2003-04-18       Impact factor: 3.201

2.  Gastrointestinal stromal tumor of the rectum.

Authors:  Y Hama; H Okizuka; K Odajima; M Hayakawa; S Kusano
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

3.  Specific mutation in exon 11 of c-kit proto-oncogene in a malignant gastrointestinal stromal tumor of the rectum.

Authors:  M Yamaguchi; M Miyaki; T Iijima; T Matsumoto; M Kuzume; A Matsumiya; Y Endo; Y Sanada; K Kumada
Journal:  J Gastroenterol       Date:  2000       Impact factor: 7.527

4.  Gastrointestinal stromal tumor of the rectal mesentery.

Authors:  Takamori Nakayama; Hayato Hirose; Kiyoshi Isobe; Kou Shiraishi; Takao Nishiumi; Syunji Mori; Yoshiaki Furuta; Masao Kasahara
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

5.  Gastrointestinal stromal tumor arising in the rectovaginal septum.

Authors:  K Nasu; T Ueda; S Kai; H Anai; Y Kimura; S Yokoyama; I Miyakawa
Journal:  Int J Gynecol Cancer       Date:  2004 Mar-Apr       Impact factor: 3.437

Review 6.  Imaging of gastrointestinal stromal tumour (GIST).

Authors:  S Lau; K F Tam; C K Kam; C Y Lui; C W Siu; H S Lam; K L Mak
Journal:  Clin Radiol       Date:  2004-06       Impact factor: 2.350

7.  Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial.

Authors:  Jaap Verweij; Paolo G Casali; John Zalcberg; Axel LeCesne; Peter Reichardt; Jean-Yves Blay; Rolf Issels; Allan van Oosterom; Pancras C W Hogendoorn; Martine Van Glabbeke; Rossella Bertulli; Ian Judson
Journal:  Lancet       Date:  2004 Sep 25-Oct 1       Impact factor: 79.321

Review 8.  Diagnosis of gastrointestinal stromal tumors: A consensus approach.

Authors:  Christopher D M Fletcher; Jules J Berman; Christopher Corless; Fred Gorstein; Jerzy Lasota; B Jack Longley; Markku Miettinen; Timothy J O'Leary; Helen Remotti; Brian P Rubin; Barry Shmookler; Leslie H Sobin; Sharon W Weiss
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

Review 9.  [Imatinib, a specific tyrosine-kinase inhibitor, for the treatment of patients with a gastrointestinal stroma cell tumor].

Authors:  H Gelderblom; P C Hogendoorn; W T van der Graaf; J Verweij
Journal:  Ned Tijdschr Geneeskd       Date:  2003-10-18

Review 10.  Biology of gastrointestinal stromal tumors.

Authors:  Christopher L Corless; Jonathan A Fletcher; Michael C Heinrich
Journal:  J Clin Oncol       Date:  2004-09-15       Impact factor: 44.544

View more
  6 in total

1.  Histopathologic study of the rectum in 1,464 consecutive rectal specimens in a single Japanese hospital: II. malignant lesions.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

2.  Transvaginal resection of a rectal gastrointestinal stromal tumor.

Authors:  Masayasu Hara; Satoru Takayama; Atsushi Arakawa; Mikinori Sato; Takaya Nagasaki; Hiromitsu Takeyama
Journal:  Surg Today       Date:  2012-06-09       Impact factor: 2.549

3.  Rectal gastrointestinal stromal tumors: imaging features with clinical and pathological correlation.

Authors:  Zhao-Xia Jiang; Sheng-Jian Zhang; Wei-Jun Peng; Bao-Hua Yu
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

4.  Gastrointestinal stromal tumor presenting with prominent calcification.

Authors:  Naoki Izawa; Takeshi Sawada; Ryuichi Abiko; Daisuke Kumon; Mami Hirakawa; Mika Kobayashi; Nobuyuki Obinata; Masahito Nomoto; Tadateru Maehata; Shun-ichi Yamauchi; Takefumi Kouro; Takashi Tsuda; Satoshi Kitajima; Hiroshi Yasuda; Keiichi Tanaka; Ichiro Tanaka; Masahiro Hoshikawa; Masayuki Takagi; Fumio Itoh
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

5.  Thick calcification from a GIST of the stomach penetrating into pericolic soft tissue--report of a case.

Authors:  Cheng-Chan Yu; Cheng-Chung Wu; Jen-I Hwang; John Wang; Chi-Sen Chang
Journal:  World J Surg Oncol       Date:  2011-04-29       Impact factor: 2.754

6.  Heavily calcified gastrointestinal stromal tumors: Pathophysiology and implications of a rare clinicopathologic entity.

Authors:  Massimiliano Salati; Giulia Orsi; Luca Reggiani Bonetti; Fabrizio Di Benedetto; Giuseppe Longo; Stefano Cascinu
Journal:  World J Gastrointest Oncol       Date:  2017-03-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.